SCHEMBL7657137

SCHEMBL7657137

O=C1Cc2cccnc2N1c1ccsc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.36
GAA P10253 4/20 0.35
TLR9 Q9NR96 2/20 0.35
PKM P14618 1/20 0.35
HCAR1 Q9BXC0 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33
CYP1A2 P05177 1/20 0.33
CHRM2 P08172 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
CYP2D6 P10635 1/20 0.33
CHRM1 P11229 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
DRD1 P21728 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1150422 0.80 HPGD (0.57) HPGDGAATLR9PKMCYP1A2
SCHEMBL9209276 0.77 MEN1 (0.46) HPGDGAATLR9PKMMEN1
SCHEMBL2345043 0.77 MAPT (0.48) HPGDGAATLR9PKMMEN1
SCHEMBL1699137 0.77 HPGD (0.41) HPGDGAATLR9PKMADRA2A
SCHEMBL2342931 0.76 HPGD (0.65) HPGDGAATLR9PKMEGLN1
SCHEMBL4695023 0.74 GAA (0.67) HPGDGAATLR9PKMCYP1A2
SCHEMBL9479623 0.73 KMT2A (0.50) HPGDGAAPKMCYP1A2CYP2C9
SCHEMBL9981134 0.72 MGLL (0.42) HPGDGAATLR9PKMHTR2A
SCHEMBL7691479 0.72 SCN2A (0.46) HPGDGAAPKMCYP1A2CYP2C9
SCHEMBL2398711 0.72 ADRA2A (0.41) CYP1A2CHRM2HTR1AADRA2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6498176-B1 INHIBITING TUMOR GROWTH VIA INHIBITION OF TUMOR-RELATED ANGIOGENESIS SMITHKLINEBEECHAM CORPORATION 2002-12-24 US disclosed
US-6369086-B1 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors SMITHKLINE BEECHAM CORPORATION 2002-04-09 US disclosed
EP-1165514-A1 3-(ANILINOMETHYLENE) OXINDOLES AS PROTEIN TYROSINE KINASE AND PROTEIN SERINE/THREONINE KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 2002-01-02 EP disclosed
WO-2000056710-A1 3-(ANILINOMETHYLENE) OXINDOLES AS PROTEIN TYROSINE KINASE AND PROTEIN SERINE/THREONINE KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 2000-09-28 WO disclosed